Wolfgang Schraut
Overview
Explore the profile of Wolfgang Schraut including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
AlMasri S, Zenati M, Papachristou G, Slivka A, Sanders M, Chennat J, et al.
Surg Endosc
. 2021 Feb;
36(1):631.
PMID: 33598813
No abstract available.
2.
AlMasri S, Zenati M, Papachristou G, Slivka A, Sanders M, Chennat J, et al.
Surg Endosc
. 2021 Feb;
36(1):621-630.
PMID: 33543349
Introduction: Treatment of pancreaticobiliary pathology following Roux-en-Y gastric bypass (RYGB) poses significant technical challenges. Laparoscopic-assisted endoscopic retrograde cholangiopancreatography (LA-ERCP) can overcome those anatomical hurdles, allowing access to the papilla. Our...
3.
Zator Z, Klinge M, Schraut W, Tsung A, Khalid A
Therap Adv Gastroenterol
. 2018 Jul;
11:1756284818785574.
PMID: 30034531
Background: Endoscopic management of pelvic abscesses not amenable to percutaneous drainage has been described. The technique employs endoscopic ultrasound (EUS)-guided placement of stents or drains, which may require multiple procedures,...
4.
Hartman D, Binion D, Regueiro M, Schraut W, Bahary N, Sun W, et al.
Am J Surg Pathol
. 2014 Jul;
38(8):1147-56.
PMID: 25029120
The underlying molecular alterations in chronic idiopathic inflammatory bowel disease-associated intestinal adenocarcinoma remain largely unknown. Somatic IDH mutations are often seen in gliomas and myeloid leukemia but have also been...
5.
Regueiro M, Kip K, Baidoo L, Swoger J, Schraut W
Clin Gastroenterol Hepatol
. 2014 Jun;
12(10):1764-5.
PMID: 24956081
No abstract available.
6.
Regueiro M, Kip K, Baidoo L, Swoger J, Schraut W
Clin Gastroenterol Hepatol
. 2014 Mar;
12(8):1407.
PMID: 24614332
No abstract available.
7.
Regueiro M, Kip K, Baidoo L, Swoger J, Schraut W
Clin Gastroenterol Hepatol
. 2014 Jan;
12(9):1494-502.e1.
PMID: 24440221
Background & Aims: A previous randomized, placebo-controlled study showed that infliximab maintenance therapy prevented recurrence of Crohn's disease 1 year after an ileocolonic resection. We evaluated recurrence of Crohn's disease,...
8.
Regueiro M, El-Hachem S, Kip K, Schraut W, Baidoo L, Watson A, et al.
Dig Dis Sci
. 2011 Jun;
56(12):3610-5.
PMID: 21681507
Background: Infliximab is effective treatment for Crohn's disease and has been associated with rare, but serious infectious complications. Emerging data suggest a benefit of infliximab in preventing postoperative Crohn's disease...
9.
Regueiro M, Kip K, Schraut W, Baidoo L, Sepulveda A, Pesci M, et al.
Inflamm Bowel Dis
. 2010 Sep;
17(1):118-26.
PMID: 20848538
Background: Crohn's disease clinical trials utilize the Crohn's Disease Activity Index (CDAI) to measure primary endpoint assessments of clinical recurrence and remission. We evaluated the extent of agreement between clinical...
10.
Regueiro M, Schraut W, Baidoo L, Kip K, Sepulveda A, Pesci M, et al.
Gastroenterology
. 2008 Dec;
136(2):441-50.e1.
PMID: 19109962
Background & Aims: Crohn's disease commonly recurs after intestinal resection. We evaluated whether the administration of infliximab after resective intestinal surgery for Crohn's disease reduces postoperative recurrence. Methods: We randomly...